Control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A survey from the MRSA 2003 GEIH/GEMARA/REIPI project;Medidas de control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Encuesta del proyecto SARM 2003 GEIH/GEMARA/REIPI

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 3, 2006, Pages 149-156

  Rodríguez Baño, Jesús ^a   Millán, Antonio B ^a   Domínguez, María Ángeles ^b   Almirante, Benito ^c   Cercenado, Emilia ^d   Padilla, Belén ^d   Pujol, Miguel ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cross infection; Health care surveys; Infection control; Methicillin resistance; Multicenter study; Nosocomial infections; Staphylococcus aureus

Indexed keywords

PSEUDOMONIC ACID;

HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL; HUMAN; INCIDENCE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OCCUPATIONAL HAZARD; PATIENT CARE; QUESTIONNAIRE; REVIEW; SPAIN; STAPHYLOCOCCUS INFECTION;

EID: 33646513742     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086546     Document Type: Article

References (35)

1. Cosgrov SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-9.
2. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-8.
3. Oteo J, Cruchaga S, Campos J, Sáez JA, Baquero F y miembros españoles del Grupo del European Antimicrobial Resistance Surveillance System (EARSS). Resistencia a antibióticos en Staphylococcus aureus aislados de sangre en 31 hospitales españoles de la red europea de vigilancia de resistencia a antibióticos (2000). Med Clin (Barc). 2002;119:361-5.
4. Cuevas O, Cercenado E, Vindel A, Guinea J, Sánchez-Conde M, Sánchez-Somolinos M, et al. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother. 2004;48:4240-5.
5. Tiemersma EW, Bronzwaer S, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis. 2004;10:1627-34.
6. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992 to June 2002, issued August 2003. Am J Infect Control. 2003;31:481-98.
7. Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian Hospitals. The gruopement pour le dépistage, l'etude et al prévention des infections hospitaliéres-Groep ter opsporing, studie en preventie van de infecties in de ziekenhuizen (GDEPIH-GOSPIZ). Acta Clin Belg. 1994;49:108-13.
8. Wenzel RP, Reagan DR, Bertino JS Jr, Baron EJ, Arias KA. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control. 1998;26:102-10.
9. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. British Society for Antimicrobial Chemotherapy Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect. 1998;39:253-90.
10. Arnold MS, Dempsey JM, Fishman M, McAuley PJ, Tibert C, Vallande NC. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol. 2002;23:69-76.
11. Muto CA, John AJ, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003;24:362-86.
12. Paterson JV. Making real sense of MRSA. Lancet. 1996;348:836-7.
13. Barret SP, Mummery RV, Chattopadhyay B. Trying to control MRSA causes more problems than it solves. J Hosp Infection. 1998;39:85-93.
14. Preheim LC, Rimland D, Bittner MJ. Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers. Infect Control. 1987;8:191-4.
15. Struelens MJ, Ronveaux O, Jans B, Mertens R. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres. Infect Control Hosp Epidemiol. 1996;17:503-8.
16. Lepelletier D, Richet H. Surveillance and control of methicillin- resistant Staphylococcus aureus infections in French Hospitals. Infect Control Hosp Epidemiol. 2001;22:677-82.
17. Hails J, Kwaku F, Wilson AP, Bellingan G, Singer M. Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Med. 2003;29:481-3.
18. Burd M, Humphreys H, Glynn G, Mitchell E, McDonald P, Johnson H, et al. Control and the prevention of methicillin-resistant Staphylococcus aureus in hospitals in Ireland: North/South Study of MRSA in Ireland 1999. J Hosp Infect. 2003;53:297-303.
19. Richet HM, Benbachir M, Brown DE, Giamarellou H, Gould I, Gubina M, et al. Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol. 2003;24:334-41.
20. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234-40.
21. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997;18:275-91.
22. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834-44.
23. Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol. 1996;17:512-3.
24. Parras F, Rodríguez M, Bouza E, Muñoz P, Cercenado E, Guerrero C, et al. Brote epidémico de Staphylococcus aureus resistente a meticilina (SARM) en un hospital general. Informe preliminar. Enferm Infecc Microbiol Clin. 1991;4:200-7.
25. Trilla A, Marco F, Moreno A, Prat A, Soriano E, Jiménez de Anta MT y el Comité de Control de Infecciones. Epidemiología clínica de un brote de infección nosocomial por Staphylococcus aureus resistente a meticilina: eficacia de las medidas de control. Med Clin (Barc). 1993;100:205-9.
26. Oteo J, Baquero F, Vindel A, Campos J on behalf of the Spanish members of The European Antimicrobial Resistance Surveillance System (EARSS). Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance surveillance System (2000-2002). J Antimicrob Chemother. 2004;53:1033-8.
27. Gastmeier P, Schwab F, Geffers C, Rüden H. To isolate or not to isolate? Analysis of data from German Nosocomial Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol. 2004;25:109-13.
28. Tomic V, Svetina Sorli S, Trinkaus D, Sorli J, Widmer A, Trampuz A. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med. 2004;164:2038-43.
29. Kotilainen P, Routamaa M, Peltonen R, Oksi J, Rintala E, Meurman O, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis. 2003;9:169-75.
30. Boyce JM, Havill NL, Kohan C, Dumingan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylcoccus aureus? Infect Control Hosp Epidemiol. 2004;25:395-401.
31. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medely GF, et al. Isolation measures in the hospital management of MRSA: a systematic review of the literature. BMJ. 2004;329:533-9.
32. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med. 1991;91 Suppl 3B:221-7.
33. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost-effective? Infect Control Hosp Epidemiol. 1999;20:473-7.
34. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus. A cost-benefit analysis in an intensive care unit. JAMA. 1999;282:1745-51.
35. Giruo E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1997;27:543-50.